---
title: "CLCN1"
date: 2023-05-12 00:00:00
layout: post
categories: Gene
summary: "# CLCN1 Gene Analysis"
tags: ['CLCN1', 'MyotoniaCongenita', 'ChlorideChannel', 'GeneticDisorder', 'Mutation', 'DrugResponse', 'Treatment', 'Prognosis']
---

# CLCN1 Gene Analysis

## Genetic Position

- Gene Name: CLCN1
- Genomic Location: Chromosome 7 (7q35)
- Orientation: minus strand
- Amino Acids: 988

## Pathology and Function

The CLCN1 gene encodes a voltage-gated chloride channel that plays a critical role in the membrane excitability of skeletal muscles and other excitable tissues. Mutations in this gene have been associated with myotonia congenita, a genetic disorder characterized by delayed muscle relaxation after contraction. Myotonia congenita can present as either Thomsen disease or Becker disease.

## Gene Information

- Function: Encodes a voltage-gated chloride channel that plays a critical role in the membrane excitability of skeletal muscles and other excitable tissues
- External IDs: 
   - HGNC: 2033
   - NCBI Entrez: 1184
   - Ensembl: ENSG00000105835
   - OMIM: 118425
   - UniProtKB/Swiss-Prot: Q05844
- Aliases: CLC-1, ClC-1, chloride channel 1, skeletal muscle

## Mutations

### AA Mutation List

- p.Arg77His (rs104893778)
- p.Arg894Ter (rs121909507)
- p.Arg894Gln (rs121909508)
- p.Gln175His (rs1555705876)
- p.Met486Val (rs72634303)

### Mutation type

- Missense
- Nonsense
- Frameshift
- Splicing

### Somatic SNVs/InDels

None reported.

## Related Diseases

- Myotonia congenita
    - Thomsen disease
    - Becker disease

## Treatment and Prognosis

There is currently no cure for myotonia congenita; treatment primarily involves management of symptoms and preventing complications. Prognosis varies depending on disease severity and individual patient factors.

## Drug Response

Multiple drugs have been reported to have some efficacy in treating myotonia congenita, including mexiletine, carbamazepine, and phenytoin. However, drug response can vary widely between individuals.

## References

- Statland JM, Fontaine B, Hanna MG, Johnson NE, Kissel JT, Sansone VA, Shieh PB, Tawil RN, Trivedi J, Cannon SC, Griggs RC. Review of the Diagnosis and Treatment of Periodic Paralysis. Muscle Nerve. 2018 Mar;57(3):522-530. doi: 10.1002/mus.25987
- Desaphy JF, Pierno S, Liantonio A, De Luca A, Didonna MP, et al. (2001) Antimyotonic effect of riluzole in myotonia congenita. Neurology 56: 445–448. doi: 10.1212/wnl.56.4.445
- Tawil R (2005) Update on therapy of myotonic disorders. Muscle Nerve 32: 5–19. doi: 10.1002/mus.20300

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**